
    
      NANT Colorectal Cancer (CRC) Vaccine: A phase 1b/2 Trial of the NANT CRC Vaccine vs
      Regorafenib in Subjects with Metastatic CRC Who Have Been Previously Treated with
      Standard-Of-Care Therapy
    
  